These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis. Jullien V; Raïs A; Urien S; Dimet J; Delaugerre C; Bouillon-Pichault M; Rey E; Pons G; Blanche S; Tréluyer JM Br J Clin Pharmacol; 2007 Jul; 64(1):105-9. PubMed ID: 17324223 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of nelfinavir in children: influencing factors and dose implications. Bergshoeff AS; Fraaij PL; van Rossum AM; Wolfs TF; Geelen SP; de Groot R; Burger DM Antivir Ther; 2003 Jun; 8(3):215-22. PubMed ID: 12924538 [TBL] [Abstract][Full Text] [Related]
31. Factors affecting antiepileptic drug pharmacokinetics in community-dwelling elderly. Cloyd JC; Marino S; Birnbaum AK Int Rev Neurobiol; 2007; 81():201-10. PubMed ID: 17433925 [TBL] [Abstract][Full Text] [Related]
32. Indexed glomerular filtration rate as a function of age and body size. Peters AM; Henderson BL; Lui D Clin Sci (Lond); 2000 Apr; 98(4):439-44. PubMed ID: 10731478 [TBL] [Abstract][Full Text] [Related]
33. [Physiological changes in pyridinoline excretion in urine depending on age and sex]. Prozorovskaia NN; Kozlov EA; Prokhorova TA; Gorokhova TA; Prozorovskiĭ VN; Del'vig AA Vopr Med Khim; 1991; 37(1):72-4. PubMed ID: 1858347 [TBL] [Abstract][Full Text] [Related]
34. [Peculiarities of pharmacokinetics in young animals]. Kietzmann M; Löscher W Berl Munch Tierarztl Wochenschr; 1990 Aug; 103(8):277-82. PubMed ID: 2206125 [TBL] [Abstract][Full Text] [Related]
35. Pharmacology in the very young: anaesthetic implications. Anderson BJ Eur J Anaesthesiol; 2012 Jun; 29(6):261-70. PubMed ID: 22543573 [TBL] [Abstract][Full Text] [Related]
36. Psychopharmacology of children and adolescents: pharmacokinetics and relationships of plasma/serum levels to response. Geller B Psychopharmacol Bull; 1991; 27(4):401-9. PubMed ID: 1813890 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic considerations in pediatric pharmacotherapy. Lim SY; Pettit RS Am J Health Syst Pharm; 2019 Sep; 76(19):1472-1480. PubMed ID: 31532503 [TBL] [Abstract][Full Text] [Related]
38. [Pharmacokinetics of 2-sulfanilamido-3-methoxy pyrazine in children (elimination, enteral absorption, distribution and dosage)]. Dost FH; Gladtke E Arzneimittelforschung; 1969 Aug; 19(8):1304-7. PubMed ID: 5820297 [No Abstract] [Full Text] [Related]
39. Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations. Strolin Benedetti M; Whomsley R; Baltes EL Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):447-71. PubMed ID: 16863455 [TBL] [Abstract][Full Text] [Related]
40. Specific features of pharmacokinetics in children. Matalová P; Urbánek K; Anzenbacher P Drug Metab Rev; 2016; 48(1):70-9. PubMed ID: 26828377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]